GENE: GTG Labs Average Forecast Price

The price chart for Genetic Technologies (GENE) illustrates the price action of an asset whose revenue is based on the implementation of genomic research for the early detection of cardiac pathologies and breast oncology, which constitutes 6.84. High throughput is achieved through the integration of robotics into the DNA sequencing process. Meanwhile, Genetic Technologies (GENE) complies with biomaterial disposal regulations and maintains basic environmental standards across its offices.

GENE (Genetic Technologies) Analyst Consensus Forecast history from 07/04/2022 to 10/26/2024

Analytical breakdowns for Genetic Technologies (GENE)

- market value and analyst target forecast:

Price Rate Chart gtglabs.com|GENE - Analyst Consensus Forecast

- market capitalization information:

Market Value GTG Labs|GENE - Total Company Value

- shareholders' equity book value data:

Equity per Share Genetic Technologies|GENE - Book Capitalization|Market-to-Book Ratio gtglabs.com|GENE - Aggregate Company Assets

- issuer credit burden and liquidity indicators:

- net income and valuation multiples indicators:

GENE - Net Profit|Projected Future Earnings Genetic Technologies|GENE - Price to Earnings Ratio|Future Price to Earnings gtglabs.com|GENE - Price/Earnings to Growth Multiple|Company Value to EBITDA GTG Labs|GENE - Profit before payment of interest, taxes and amortization|Net earnings per share for the last four quarters Genetic Technologies|GENE - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months gtglabs.com|GENE - Earnings per share growth in current year|Consensus forecast of earnings per share growth for next year Genetic Technologies

General company analysis:Genetic Technologies Ltd (GENE)

Genetic Technologies possesses strong pricing power in the preventive genetics segment, and the low demand elasticity for geneType tests creates a foundation for a premium business valuation. The volume-weighted average share price of 6.84 digitizes the institutional consensus, where the consensus fair value forecast captures shifts in analyst sentiment, allowing investors to timely identify market trend inflection points.

Competing companies